Company news

Pulmatrix, Inc. news in 2021

Pulmatrix, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Pulmatrix Announces Closing of $6.75 Million Registered Direct Offering

December 16, 2021

Pulmatrix Announces $6.75 Million Registered Direct Offering

December 14, 2021

Pulmatrix Reports Third Quarter 2021 Financial Results and Provides Business Update

November 9, 2021

Pulmatrix Announces Resolution of Contract Dispute with Cipla

November 8, 2021

Pulmatrix Reports Second Quarter 2021 Financial Results and Provides Business Update

August 9, 2021

Pulmatrix appoints Director Anand Varadan

July 26, 2021

Pulmatrix Reports First Quarter 2021 Financial Results and Provides Business Update

May 10, 2021

Pulmatrix Hosting Key Opinion Webinar on PUR3100 (Orally Inhaled DHE) Therapy for the Treatment of Acute Migraine

April 14, 2021

Pulmatrix to Regain Full Rights to PUR1800 and Narrow Spectrum Kinase Inhibitor Portfolio

April 11, 2021

Pulmatrix Reports 2020 Financial Results and Provides Business Update

March 22, 2021

Pulmatrix Provides a Pipeline and Business Update

March 3, 2021

Pulmatrix Announces Closing of $40 Million Registered Direct Offering

February 15, 2021

Pulmatrix Announces $40 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

February 10, 2021

Decks in 2021